140 related articles for article (PubMed ID: 29392314)
1. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
Amer R; Tiosano L; Pe'er J
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
3. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: correlation between clinical, MR imaging, and histopathologic findings.
de Graaf P; van der Valk P; Moll AC; Imhof SM; Schouten-van Meeteren AY; Knol DL; Castelijns JA
AJNR Am J Neuroradiol; 2010 Feb; 31(2):237-45. PubMed ID: 19833805
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef NS; Said AM
Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
[TBL] [Abstract][Full Text] [Related]
6. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
7. Expression of C-kit in retinoblastoma: a potential therapeutic target.
Barry RJ; de Moura LR; Marshall JC; Fernandes BF; Orellana ME; Antecka E; Martins C; Burnier MN
Br J Ophthalmol; 2007 Nov; 91(11):1532-6. PubMed ID: 17591671
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological parameters and expression of P-glycoprotein and MRP-1 in retinoblastoma.
Kamburoğlu G; Kiratli H; Söylemezoğlu F; Bilgiç S
Ophthalmic Res; 2007; 39(4):191-7. PubMed ID: 17596751
[TBL] [Abstract][Full Text] [Related]
9. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor in retinoblastoma.
Areán C; Orellana ME; Abourbih D; Abreu C; Pifano I; Burnier MN
Arch Ophthalmol; 2010 Feb; 128(2):223-9. PubMed ID: 20142546
[TBL] [Abstract][Full Text] [Related]
11. EpCAM expression in retinoblastoma: a novel molecular target for therapy.
Krishnakumar S; Mohan A; Mallikarjuna K; Venkatesan N; Biswas J; Shanmugam MP; Ren-Heidenreich L
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4247-50. PubMed ID: 15557427
[TBL] [Abstract][Full Text] [Related]
12. Expression of pro-apoptotic Bax and anti-apoptotic Bcl-2 proteins in human retinoblastoma.
Singh L; Pushker N; Saini N; Sen S; Sharma A; Bakhshi S; Chawla B; Kashyap S
Clin Exp Ophthalmol; 2015 Apr; 43(3):259-67. PubMed ID: 25132102
[TBL] [Abstract][Full Text] [Related]
13. Photoreceptor cell differentiation in retinoblastoma demonstrated by a new immunohistochemical marker mucin-like glycoprotein associated with photoreceptor cells (MLGAPC).
Tsuji M; Goto M; Uehara F; Kaneko A; Sawai J; Yonezawa S; Ohba N
Histopathology; 2002 Feb; 40(2):180-6. PubMed ID: 11952864
[TBL] [Abstract][Full Text] [Related]
14. Expression of CDC25A and CDC25B phosphatase proteins in human retinoblastoma and its correlation with clinicopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Bakhshi S; Chawla B; Kashyap S
Br J Ophthalmol; 2015 Apr; 99(4):457-63. PubMed ID: 25326518
[TBL] [Abstract][Full Text] [Related]
15. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study.
Eagle RC
Arch Pathol Lab Med; 2009 Aug; 133(8):1203-9. PubMed ID: 19653710
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
17. Heat shock proteins and survivin: relationship and effects on proliferation index of retinoblastoma cells.
Jiang LB; Liu XQ; Li B; He XJ; Jin YL; Li LQ; Gao F; Wang NL
Histol Histopathol; 2008 Jul; 23(7):827-31. PubMed ID: 18437681
[TBL] [Abstract][Full Text] [Related]
18. Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
Souza Filho JP; Martins MC; Caissie AL; Torres VL; Fernandes LH; Erwenne CM; Burnier MN
Clin Exp Ophthalmol; 2005 Jun; 33(3):279-84. PubMed ID: 15932532
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Analysis of PDGFR-α, PDGFR-β and c-Abl in Retinoblastoma: Potential Therapeutic Targets.
Sanft DM; Worme MD; Rielo de Moura L; Zoroquiain P; Fernandes BF; Antecka E; Burnier MN
Ophthalmic Res; 2016; 55(3):159-62. PubMed ID: 26761215
[TBL] [Abstract][Full Text] [Related]
20. High expression of TAZ indicates a poor prognosis in retinoblastoma.
Zhang Y; Xue C; Cui H; Huang Z
Diagn Pathol; 2015 Oct; 10():187. PubMed ID: 26464030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]